David J. Woodhouse serves as Executive at NGM BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, David J. Woodhouse has executed 8 insider transactions totaling $300.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 5, 2024 involved transacting 97,654 shares valued at $0.
David J. Woodhouse currently holds 131,822 shares of NGM BIOPHARMACEUTICALS INC (NGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David J. Woodhouse has been a net seller of NGM stock. They have purchased $0 and sold $300.3K worth of shares.
David J. Woodhouse's most recent insider trade was on Apr 5, 2024, when they sold 97,654 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 16, 2024 | NGM | $17.5K | Payment | 13,032 | $1.34 | Discretionary |
| Mar 2, 2023 | NGM | $0 | Award | 127,200 | $N/A | Discretionary |
| Dec 29, 2021 | NGM | $38.0K | Option Exercise | 4,667 | $8.14 | Discretionary |
| Dec 29, 2021 | NGM | $100.0K | Option Exercise | 12,987 | $7.70 | Discretionary |
| Nov 18, 2021 | NGM | $300.3K | Sale | 15,000 | $20.02 | Discretionary |
| Nov 18, 2021 | NGM | $113.1K | Option Exercise | 15,000 | $7.54 | Discretionary |